Cargando…
What is the Pathogenic CAG Expansion Length in Huntington’s Disease?
Huntington’s disease (HD) (OMIM 143100) is caused by an expanded CAG repeat tract in the HTT gene. The inherited CAG length is known to expand further in somatic and germline cells in HD subjects. Age at onset of the disease is inversely correlated with the inherited CAG length, but is further modul...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990448/ https://www.ncbi.nlm.nih.gov/pubmed/33579866 http://dx.doi.org/10.3233/JHD-200445 |
_version_ | 1783669075385253888 |
---|---|
author | Donaldson, Jasmine Powell, Sophie Rickards, Nadia Holmans, Peter Jones, Lesley |
author_facet | Donaldson, Jasmine Powell, Sophie Rickards, Nadia Holmans, Peter Jones, Lesley |
author_sort | Donaldson, Jasmine |
collection | PubMed |
description | Huntington’s disease (HD) (OMIM 143100) is caused by an expanded CAG repeat tract in the HTT gene. The inherited CAG length is known to expand further in somatic and germline cells in HD subjects. Age at onset of the disease is inversely correlated with the inherited CAG length, but is further modulated by a series of genetic modifiers which are most likely to act on the CAG repeat in HTT that permit it to further expand. Longer repeats are more prone to expansions, and this expansion is age dependent and tissue-specific. Given that the inherited tract expands through life and most subjects develop disease in mid-life, this implies that in cells that degenerate, the CAG length is likely to be longer than the inherited length. These findings suggest two thresholds— the inherited CAG length which permits further expansion, and the intracellular pathogenic threshold, above which cells become dysfunctional and die. This two-step mechanism has been previously proposed and modelled mathematically to give an intracellular pathogenic threshold at a tract length of 115 CAG (95% confidence intervals 70– 165 CAG). Empirically, the intracellular pathogenic threshold is difficult to determine. Clues from studies of people and models of HD, and from other diseases caused by expanded repeat tracts, place this threshold between 60– 100 CAG, most likely towards the upper part of that range. We assess this evidence and discuss how the intracellular pathogenic threshold in manifest disease might be better determined. Knowing the cellular pathogenic threshold would be informative for both understanding the mechanism in HD and deploying treatments. |
format | Online Article Text |
id | pubmed-7990448 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | IOS Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-79904482021-04-14 What is the Pathogenic CAG Expansion Length in Huntington’s Disease? Donaldson, Jasmine Powell, Sophie Rickards, Nadia Holmans, Peter Jones, Lesley J Huntingtons Dis Review Huntington’s disease (HD) (OMIM 143100) is caused by an expanded CAG repeat tract in the HTT gene. The inherited CAG length is known to expand further in somatic and germline cells in HD subjects. Age at onset of the disease is inversely correlated with the inherited CAG length, but is further modulated by a series of genetic modifiers which are most likely to act on the CAG repeat in HTT that permit it to further expand. Longer repeats are more prone to expansions, and this expansion is age dependent and tissue-specific. Given that the inherited tract expands through life and most subjects develop disease in mid-life, this implies that in cells that degenerate, the CAG length is likely to be longer than the inherited length. These findings suggest two thresholds— the inherited CAG length which permits further expansion, and the intracellular pathogenic threshold, above which cells become dysfunctional and die. This two-step mechanism has been previously proposed and modelled mathematically to give an intracellular pathogenic threshold at a tract length of 115 CAG (95% confidence intervals 70– 165 CAG). Empirically, the intracellular pathogenic threshold is difficult to determine. Clues from studies of people and models of HD, and from other diseases caused by expanded repeat tracts, place this threshold between 60– 100 CAG, most likely towards the upper part of that range. We assess this evidence and discuss how the intracellular pathogenic threshold in manifest disease might be better determined. Knowing the cellular pathogenic threshold would be informative for both understanding the mechanism in HD and deploying treatments. IOS Press 2021-02-09 /pmc/articles/PMC7990448/ /pubmed/33579866 http://dx.doi.org/10.3233/JHD-200445 Text en © 2021 – The authors. Published by IOS Press https://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial (CC BY-NC 4.0) License (https://creativecommons.org/licenses/by-nc/4.0/) , which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Donaldson, Jasmine Powell, Sophie Rickards, Nadia Holmans, Peter Jones, Lesley What is the Pathogenic CAG Expansion Length in Huntington’s Disease? |
title | What is the Pathogenic CAG Expansion Length in Huntington’s Disease? |
title_full | What is the Pathogenic CAG Expansion Length in Huntington’s Disease? |
title_fullStr | What is the Pathogenic CAG Expansion Length in Huntington’s Disease? |
title_full_unstemmed | What is the Pathogenic CAG Expansion Length in Huntington’s Disease? |
title_short | What is the Pathogenic CAG Expansion Length in Huntington’s Disease? |
title_sort | what is the pathogenic cag expansion length in huntington’s disease? |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990448/ https://www.ncbi.nlm.nih.gov/pubmed/33579866 http://dx.doi.org/10.3233/JHD-200445 |
work_keys_str_mv | AT donaldsonjasmine whatisthepathogeniccagexpansionlengthinhuntingtonsdisease AT powellsophie whatisthepathogeniccagexpansionlengthinhuntingtonsdisease AT rickardsnadia whatisthepathogeniccagexpansionlengthinhuntingtonsdisease AT holmanspeter whatisthepathogeniccagexpansionlengthinhuntingtonsdisease AT joneslesley whatisthepathogeniccagexpansionlengthinhuntingtonsdisease |